# Version History

## SAD v4.0 (February 2026) -- CURRENT

**Major additions:**
- Complete bench protocol for Experiment 2a/2b (Section 3.2, pp. 10-14)
  - Lovastatin prodrug activation protocol
  - Mitochondrial isolation procedure
  - Amplex Red cholesterol quantification
  - Filipin staining with MitoTracker colocalization
  - EGS cross-linking + Western blot for VDAC1 oligomerization
  - Full reagent list with catalog numbers
  - Estimated budget: $3,010
  - 4-week execution timeline
  - Statistical analysis plan
- Breast (TNBC) added to Table 1 as fourth cancer type
- Table 3 restructured: now organized by mechanistic evidence chain rather than lifestyle interventions
- Full abbreviations and acronyms glossary (2 pages)
- Publication-ready formatting: TOC, running headers, page numbers, embedded figures
- Closing Statement section added

**Synthesis:** Claude Opus 4.6, Gemini 2.5 Pro, Grok, Claude Sonnet 4.5

---

## SAD v3.0 (February 2026)

**Key changes from v2:**
- Expanded from 4 to 6 experiments (added Exp 5: dual-lock synergy, Exp 6: CBD rehabilitation)
- Complete reagent and cell line specifications in Table 2
- Chou-Talalay Combination Index analysis for dual-lock targeting
- Q2-Q4 2026 operational roadmap with 5 phases (A-E)
- Validated support mechanisms table with evidence grades
- Experiment dependency graph formalized

---

## SAD v2.0 (February 2026)

**Key changes from v1:**
- Added TSPO cautions section:
  - Binding ambiguity (stabilize vs destabilize)
  - Overexpression paradox (compensatory vs causal)
  - PK11195 selectivity concerns at >10 uM
- Expanded experiment and reference tables
- Multi-model synthesis approach introduced

---

## SAD v1.0 (February 2026)

**Original document:**
- Gate-Jamming Score (GJS) cofactor equation introduced
- Three-lock model (HK-II, Bcl-xL, Cholesterol)
- TSPO reframed from mitophagy regulator to physical tether (fourth lock candidate)
- Lovastatin identified as primary gate opener for MSS CRC
- Botensilimab cavalry concept established
- CBD formally quarantined from immune window
- Four original experiments with kill conditions
- Original falsification of three-phase hypothesis documented

**Synthesis:** Gemini 2.5 Pro
